The US Food and Drug Administration (USFDA) has given Zydus Lifesciences permission to market Levothyroxine Sodium injection, which is used to treat thyroid hormone insufficiency. The US Food and Drug Administration (USFDA) has given the company’s US-based division preliminary authorisation to market the treatment, the pharmaceutical company reported in a regulatory filing.
Shopping Cart